vs
Gorilla Technology Group Inc.（GRRR）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Gorilla Technology Group Inc.的1.9倍（$75.5M vs $39.3M），Gorilla Technology Group Inc.同比增速更快（90.2% vs 27.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-12.8M）
Gorilla Technology Group Inc.是一家全球AI技术解决方案供应商，核心业务涵盖智能视频分析、智慧城市平台及网络安全产品，面向亚太、北美、欧洲等地区的政府机构、企业客户与商业合作伙伴提供服务，助力客户提升运营效率与安全保障能力。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GRRR vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.9倍
$39.3M
营收增速更快
GRRR
高出62.5%
27.7%
自由现金流更多
PBYI
多$27.2M
$-12.8M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.3M | $75.5M |
| 净利润 | $-8.5M | — |
| 毛利率 | 34.2% | 69.3% |
| 营业利润率 | -23.1% | 22.7% |
| 净利率 | -21.6% | — |
| 营收同比 | 90.2% | 27.7% |
| 净利润同比 | -627.6% | — |
| 每股收益（稀释后） | $-0.43 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GRRRPBYI
| Q4 25 | — | $75.5M | ||
| Q3 25 | — | $54.5M | ||
| Q2 25 | $39.3M | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | — | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | $20.7M | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润GRRRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | $-8.5M | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | $1.6M | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率GRRRPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | 34.2% | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | 85.5% | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GRRRPBYI
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | -23.1% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | 8.6% | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率GRRRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | -21.6% | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | 7.8% | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）GRRRPBYI
| Q4 25 | — | $0.26 | ||
| Q3 25 | — | $0.17 | ||
| Q2 25 | $-0.43 | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | — | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | $0.15 | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.1M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $98.2M | $130.3M |
| 总资产 | $162.7M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GRRRPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | $10.1M | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $11.2M | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务GRRRPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | $7.4M | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GRRRPBYI
| Q4 25 | — | $130.3M | ||
| Q3 25 | — | $115.3M | ||
| Q2 25 | $98.2M | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | — | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | $72.1M | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产GRRRPBYI
| Q4 25 | — | $216.3M | ||
| Q3 25 | — | $202.9M | ||
| Q2 25 | $162.7M | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | — | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | $133.1M | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比GRRRPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | 0.10× | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-12.5M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-12.8M | $14.4M |
| 自由现金流率自由现金流/营收 | -32.7% | 19.1% |
| 资本支出强度资本支出/营收 | 0.8% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GRRRPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-12.5M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $-11.3M | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流GRRRPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-12.8M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $-11.6M | $1.0M | ||
| Q1 24 | — | — |
自由现金流率GRRRPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -32.7% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | -56.2% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度GRRRPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | 0.8% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 1.8% | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率GRRRPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -6.99× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
